The Valley Desk

Clinical trial reportAdvances in respiratory medicinePublished

RNA Polymerase Inhibitor Enisamium for Treatment of Moderate COVID-19 Patients: A Randomized, Placebo-Controlled, Multicenter, Double-Blind Phase 3 Clinical Trial

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Princeton University. Affiliation source

Publication record

Type
Clinical trial report
Venue
Advances in respiratory medicine
Published
Subject terms
Humans; Antiviral Agents; Treatment Outcome; Severity of Illness Index; Double-Blind Method; Adult; Middle Aged; Female; Male; COVID-19; COVID-19 Drug Treatment; RNA polymerase
PubMed ID
38804439
PubMed Central ID
PMC11130936
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal